Press Releases

AdvaMed Welcomes the UK Government’s Commitment to Address Elective Recovery and Access to Care

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed), working in the United Kingdom with the Medical Technology Group (MTG) and the Association of British HealthTech Industries (ABHI), commends the recent announcement by the UK Government of aggressive polices to address access to care challenges that have been exacerbated by the COVID-19 pandemic. MTG has consistently highlighted elective care backlogs, access to treatment, and patient waiting times as key issues in need of comprehensive, urgent government action.  The need for action is even greater in the aftermath of COVID-19.  

“AdvaMed is focused on improving access to and the quality of patient care around the world, and I am pleased that through our partnerships with the Medical Technology Group and the Association of British HealthTech Industries, we were successful in securing greater investments for UK patients,” said AdvaMed President and CEO Scott Whitaker. “We welcome this announcement from the UK Government, and we look forward to continuing our work with our partners at home and abroad to achieve our mutual goal to improve public health.”

The UK Government set out specific and comprehensive measures in its Delivery Plan last week, that includes the following commitments:

According to the UK’s Secretary of Health, these measures will allow the NHS to perform at least 9 million extra tests, checks and procedures by 2025 and around 30% more elective activity each year in 3 years’ time than it was doing before the pandemic. 

# # #

AdvaMed member companies produce the medical devices, diagnostic products and digital health technologies that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit